Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter studyYan Zhang, Bo Shen, Yong Mao et al.|Annals of Translational Medicine|2022Cited by 10
1455P A single-arm, open-label, prospective, multicenter study of apatinib combined with chemotherapy as second-line therapy in patients with advanced gastric cancerJ. Feng, Liang Shi, Bo Shen et al.|Annals of Oncology|2020Cited by 0